1Maisel A, Krishnaswamy P, Nowak R, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347(3): 161.
2Ishii J, Nomura M, Nakamura Y, et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol, 2002, 89(6): 691.
3Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure what's next? Circulation,2002, 105: 2328.
4Troughton RW, Frampton C M, Yandle T G, et al. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide concentrations. Lancet, 2000, 355: 1126.
5Lemos JA,David AM. Brain natriuretic peptide measurement in acute coronary syndromes ready for clinical application. Circulation, 2002, 106: 2868.
6Stefan DA, Wolfram D, Mathias R, et al. Uric acid and survival in chronic heart failure. Circulation. 2003, 107:1991.
7[1]Cowie MR,Mendez GF.BNP and congestive heart failure.Prog cardiovasc Dis,2002,44:293-321.
8[3]Luchner A, Stevens TL,Borgeson DD,et a1. Differential atria and ventricular expression of myocardial BNP during evolution of heart failure.Am J Physiol,1998,274:H1684-1689.
9[4]Dickstein K.Natriuretic peptides in detection of heart failure.Lancet,1998,280:i983.
10[5]Clerio A,lervasi G,Ckicca M,et al.Circulating levels of carolac natrluretuc peptides(ANP ant BNP)measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart fdilure.J Endocrinol Invest,1998,21:170-179.
